Table 1.
Any AC visit n (%) | No AC visit n (%) | P-value | |
---|---|---|---|
Age, median (interquartile range) | 60.6 (52.0–70.1) | 63.1 (53.6–70.1) | 0.44 |
Sex | 0.14 | ||
Female | 19 (45.2%) | 106 (57.9%) | |
Male | 23 (54.8%) | 77 (42.1%) | |
Race and ethnicity | 0.91 | ||
White non-Hispanic | 30 (71.4%) | 138 (75.4%) | |
Any Hispanic or Latino | 7 (16.7%) | 25 (13.7%) | |
Black or African American Non-Hispanic | 4 (9.5%) | 15 (8.2%) | |
Asian Non-Hispanic | 1 (2.4%) | 5 (2.7%) | |
Education | 0.90 | ||
Less than high school | 1 (2.4%) | 4 (2.2%) | |
High school or GED | 6 (14.3%) | 37 (20.2%) | |
Some college, associate degree or trade certification | 17 (40.5%) | 72 (39.3%) | |
College degree (BS, BA) | 10 (23.8%) | 43 (23.5%) | |
Graduate degree (MS, MA) | 5 (11.9%) | 18 (9.8%) | |
Advanced degree (PhD, MD, JD) | 3 (7.1%) | 8 (4.4%) | |
No response | 0 (0.0%) | 1 (0.6%) | |
Household income | 0.50 | ||
$0–$19,999 | 3 (7.3%) | 16 (8.8%) | |
$20,000–$49,999 | 11 (26.8%) | 30 (16.6%) | |
$50,000–$74,999 | 6 (14.6%) | 32 (17.7%) | |
$75,000 or more | 21 (51.2%) | 103 (56.9%) | |
Insurance | 1.00 | ||
Employer or marketplace-based | 23 (54.7%) | 99 (54.1%) | |
Medicaid | 1 (2.4%) | 5 (2.7%) | |
Medicare | 17 (40.5%) | 74 (40.4%) | |
Other | 1 (2.4%) | 5 (2.7%) | |
Cancer type | < 0.001 | ||
Breast | 7 (16.7%) | 75 (41.0%) | |
Central nervous system | 1 (2.4%) | 3 (1.6%) | |
Gastrointestinal | 11 (26.2%) | 13 (7.1%) | |
Gynecological | 3 (7.1%) | 4 (2.2%) | |
Head and neck | 8 (19.1%) | 18 (9.8%) | |
Leukemia/lymphoma/myeloma | 4 (9.5%) | 11 (6.0%) | |
Lung | 6 (14.3%) | 18 (9.8%) | |
Prostate | 0 (0.0%) | 28 (15.3%) | |
Other | 2 (4.8%) | 13 (7.1%) | |
Disease extent | 0.001 | ||
Local | 7 (16.7%) | 90 (49.2%) | |
Regional | 16 (38.1%) | 50 (27.3%) | |
Distant | 15 (35.7%) | 35 (19.1%) |
The bold values indicate P < 0.05.